Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials.
Saved in:
| Title: | Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. |
|---|---|
| Authors: | Davison BA; Momentum Research, Inc., Durham, NC, USA. Electronic address: bethdavison@momentum-research.com., Harrison SA; Hepatology, Radcliffe Department of Medicine, University of Oxford, UK., Cotter G; Momentum Research, Inc., Durham, NC, USA., Alkhouri N; Texas Liver Institute, San Antonio, TX, USA., Sanyal A; Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Edwards C; Momentum Research, Inc., Durham, NC, USA., Colca JR; Cirius Therapeutics, Inc., San Diego, CA, USA., Iwashita J; Cirius Therapeutics, Inc., San Diego, CA, USA., Koch GG; University of North Carolina, Chapel Hill, NC, USA., Dittrich HC; Cirius Therapeutics, Inc., San Diego, CA, USA. |
| Source: | Journal of hepatology [J Hepatol] 2020 Dec; Vol. 73 (6), pp. 1322-1332. Date of Electronic Publication: 2020 Jun 28. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1600-0641 |
|---|---|
| DOI: | 10.1016/j.jhep.2020.06.025 |
